TUMIR: an experimentally supported database of microRNA deregulation in various cancers

BackgroundMicroRNAs were found to play an important role in cancers and several literatures exist to describe the relationship between microRNA and cancer, but the expression pattern was still faintly. There is a need for a comprehensive collection and summary of the interactions under experimental support.DescriptionTUMIR (http://www.ncrnalab.com/TUMIR/), a manually extracted database of experimentally supported microRNA-cancer relationship, aims at providing a large, high-quality, validated comprehensive resource of microRNA deregulation in various cancers. The current version includes a systematic literature search to May-1-2012 using PubMed database, contains data extracted from 205 literatures and 1163 entries describing a regulatory interaction between human microRNAs and cancers. Each entry in the database contains the details of microRNA name, the disease name, case number, control number, p value, the experimentally validated targets, sample type, and a brief description of patients’ clinic pathologic parameters mentioned in the same paper. The website has several extensive external links to the related websites and any requests can be made by emailing to tumir_pumc@163.com.ConclusionTUMIR is an open access website and will be an accurate clue for the researchers who are interested in better understanding the relationship between miRNAs and cancer.

[1]  K. Gunsalus,et al.  Combinatorial microRNA target predictions , 2005, Nature Genetics.

[2]  François Chevenet,et al.  OligoHeatMap (OHM): an online tool to estimate and display hybridizations of oligonucleotides onto DNA sequences , 2008, Nucleic Acids Res..

[3]  Wayne Tam,et al.  MicroRNAs in tumorigenesis: a primer. , 2007, The American journal of pathology.

[4]  T. Pabst,et al.  The tumour-suppressive miR-29a/b1 cluster is regulated by CEBPA and blocked in human AML , 2010, British Journal of Cancer.

[5]  Doron Betel,et al.  The microRNA.org resource: targets and expression , 2007, Nucleic Acids Res..

[6]  Sanghyuk Lee,et al.  miRGator: an integrated system for functional annotation of microRNAs , 2007, Nucleic Acids Res..

[7]  P. Fraser,et al.  No-Nonsense Functions for Long Noncoding RNAs , 2011, Cell.

[8]  J. Yun,et al.  Effects of MicroRNA‐29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma , 2009, Hepatology.

[9]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[10]  Jun Yu,et al.  Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps , 2011, Gut.

[11]  Molly Megraw,et al.  miRGen: a database for the study of animal microRNA genomic organization and function , 2006, Nucleic Acids Res..

[12]  Di Wu,et al.  miRCancer: a microRNA-cancer association database constructed by text mining on literature , 2013, Bioinform..

[13]  Yadong Wang,et al.  miR2Disease: a manually curated database for microRNA deregulation in human disease , 2008, Nucleic Acids Res..

[14]  J. Rinn,et al.  lincRNAs act in the circuitry controlling pluripotency and differentiation , 2011, Nature.

[15]  Changning Liu,et al.  dbDEMC: a database of differentially expressed miRNAs in human cancers , 2010, BMC Genomics.

[16]  Feng Jiang,et al.  Plasma microRNAs as potential biomarkers for non-small-cell lung cancer , 2010, Laboratory Investigation.

[17]  S. Luo,et al.  Global identification of microRNA–target RNA pairs by parallel analysis of RNA ends , 2008, Nature Biotechnology.

[18]  Harikrishna Nakshatri,et al.  Persistent upregulation of U6:SNORD44 small RNA ratio in the serum of breast cancer patients , 2011, Breast Cancer Research.

[19]  Patterns of known and novel small RNAs in human cervical cancer. , 2007, Cancer research.

[20]  C. Burge,et al.  Prediction of Mammalian MicroRNA Targets , 2003, Cell.

[21]  Qiong Shao,et al.  MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. , 2008, RNA.

[22]  M. Ceccarelli,et al.  Upregulation of miR-21 by Ras in vivo and its role in tumor growth , 2011, Oncogene.

[23]  Stijn van Dongen,et al.  miRBase: tools for microRNA genomics , 2007, Nucleic Acids Res..

[24]  Vassilis Georgoulias,et al.  Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR. , 2008, Clinical chemistry.

[25]  Howard Y. Chang,et al.  Long noncoding RNAs and human disease. , 2011, Trends in cell biology.

[26]  Tongbin Li,et al.  miRecords: an integrated resource for microRNA–target interactions , 2008, Nucleic Acids Res..

[27]  H. Lodish,et al.  Long noncoding RNA-mediated anti-apoptotic activity in murine erythroid terminal differentiation. , 2011, Genes & development.

[28]  C. Croce,et al.  miRNAs, Cancer, and Stem Cell Division , 2005, Cell.

[29]  A. Hatzigeorgiou,et al.  TarBase: A comprehensive database of experimentally supported animal microRNA targets. , 2005, RNA.